The Effect of Prophylactic Ephedrine on Systemic Hypotension Caused by Induction of Anaesthesia with Propofol and Sufentanil in Elderly Hypertensive Patients: A Prospective Randomized, Double-blind Placebo-controlled Clinical Trial

被引:0
|
作者
Zhang Xinpei [1 ]
Yin Kaiyu [2 ]
Huang Yabei [1 ]
Peng Mingqing [1 ]
机构
[1] Chongqing Med Univ, Dept Anesthesiol, Yongchuan Affiliated Hosp, Chongqing, Peoples R China
[2] Sichuan Univ, West China Univ Hosp 2, Dept Anesthesiol, Chengdu, Peoples R China
关键词
Ephedrine; Elderly; Hypertension; General anesthesia; METAANALYSIS; AGE;
D O I
10.22514/sv.2020.16.0081
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To study the effectiveness of prophylactic ephedrine to prevent hypotension caused by induction of anesthesia with propofol and sufentanil in elderly hypertensive patients. Methodology: 70 elderly ASA grade II-III hypertensive patients undergoing elective general anesthesia were randomized into two groups to receive either intravenous ephedrine,100 ug/kg in 5ml normal saline (Group B), or an equal volume of normal saline (Group A) before induction. Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Heart Rate (HR) were recorded at T0 (after entry to the operating room), T1 (1 min after induction), T2 (2 min after induction), T3 (3 min after induction), T4 (4 min after induction), T5 (when intubated), T6 (2 min after intubation), and T7 (at the start of the procedure), as well as the incidence of hypotension and bradycardia. Results: SBP, DBP and HR were not significantly different at T0 and were significantly different at T1 to T7 after anesthesia induction. There were statistically significant effect on hypotension and bradycardia between the two groups and group B have a lower risk of hypotension and bradycardia relative to group A. SBP and DBP decreased significantly after induction in both groups. HR decreased significantly in group A while increased in group B. Conclusion: Ephedrine pretreatment can minimize hypotension and bradycardia caused by propofol and sufentanil during the induction of general anesthesia in elderly patients with hypertension.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 50 条
  • [31] The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial
    Abbasi, Behnood
    Kimiagar, Masud
    Sadeghniiat, Khosro
    Shirazi, Minoo M.
    Hedayati, Mehdi
    Rashidkhani, Bahram
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (12): : 1161 - 1169
  • [32] The effect of prophylactic metaraminol on systemic hypotension caused by induction of anaesthesia with propofol in patients over 55 years old
    Chiu, CL
    Tew, GP
    Wang, CY
    ANAESTHESIA, 2001, 56 (09) : 893 - 897
  • [33] JinqiJiangtang tablets for prediabetes: A randomized, double-blind and placebo-controlled clinical trial
    Wang, Hui
    Guo, Liping
    Shang, Hongcai
    Ren, Ming
    Wang, Xuemei
    Wang, Dehui
    Chen, Jianzong
    Li, Shuanglei
    Chen, Liming
    Wang, Yue
    Liu, Zhi
    Zhai, Jingbo
    Song, Yuzhen
    Cao, Hongbo
    Zhang, Junhua
    Liu, Chunxiang
    Sun, Xiao
    Huo, Da
    Mu, Wei
    Zhang, Li
    Zheng, Wenke
    Yan, Xiaoyan
    Yao, Chen
    SCIENTIFIC REPORTS, 2017, 7
  • [34] CHOLECALCIFEROL SUPPLEMENTATION AND INFLAMMATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Seibert, Eric
    Ulrich, Christof
    Trojanowicz, Bogusz
    Lehmann, Ulrike
    Dierkes, Jutta
    Stangl, Gabriele I.
    Girndt, Matthias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [35] Immunomodulatory Effects of Saffron: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Kianbakht, S.
    Ghazavi, A.
    PHYTOTHERAPY RESEARCH, 2011, 25 (12) : 1801 - 1805
  • [36] Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial
    Ranasinghe, Priyanga
    Wathurapatha, Wasundara S.
    Galappatthy, Priyadarshani
    Katulanda, Prasad
    Jayawardena, Ranil
    Constantine, Godwin R.
    JOURNAL OF DIABETES, 2018, 10 (05) : 386 - 397
  • [37] A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Omalizumab For Chronic Rhinosinusitis
    Mehta, N. J.
    Pinto, J.
    de Tineo, M.
    Baroody, F. M.
    Naclerio, R. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S201 - S201
  • [38] Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
    Jain, Mamta K.
    De Lemos, James A.
    McGuire, Darren K.
    Ayers, Colby.
    Eitson, Jennifer L.
    Sanchez, Claudia L.
    Kamel, Dena
    Meisner, Jessica A.
    Thomas, Emilia V.
    Hegde, Anita A.
    Mocherla, Satish
    Strebe, Joslyn K.
    Li, Xilong
    Williams, Noelle S.
    Xing, Chao
    Ahmed, Mahmoud S.
    Wang, Ping
    Sadek, Hesham A.
    Schoggins, John W.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] CLINICAL EFFICACY OF INTRAVENOUS LIDOCAINE FOR THYROIDECTOMY: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
    Oh, J.
    Choi, G. J.
    Kang, H.
    Baek, C.
    Jung, Y. H.
    Ko, J. S.
    ANESTHESIA AND ANALGESIA, 2016, 123 : 573 - 573
  • [40] Effect of sulpiride on menopausal hot flashes: a randomized, double-blind, placebo-controlled clinical trial
    Moreira Borba, Clarissa
    Francisco Ferreira, Charles
    Vargas Ferreira, Fernanda
    Perez-Lopez, Faustino R.
    Osorio Wender, Maria Celeste
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (03) : 247 - 251